Zou Yue, Zhao Jingling, Li Chengyin, Wang Rui, Jiang Xiaocui, Zhu Zhongyi, Wang Qiyuan, Xiao Min
Department of Physical Education and Health, Hubei University of Chinese Medicine, Wuhan, China.
Department of Gynecology, Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China.
Transl Cancer Res. 2025 Feb 28;14(2):1311-1322. doi: 10.21037/tcr-24-1421. Epub 2025 Feb 17.
BACKGROUND: Gastric cancer (GC) is a malignant tumor of the digestive tract originating from the epithelial cells of the gastric mucosa, which is highly invasive and heterogeneous, posing a serious threat to human health. In recent years, ferroptosis, as a novel mode of programmed cell death, has shown potential anticancer effects in tumor therapy. Total Astragalus saponins (TAS), a natural product derived from Astragalus membranaceus, have been shown to possess various pharmacological activities, including anticancer effects. This study aimed to investigate the effects of TAS on GC cells, focusing on the mechanism of action of its regulation of the silent information regulator 3 (SIRT3) in inducing ferroptosis in GC cells. METHODS: We treated SGC-7901 cells with TAS at concentrations of 50, 100, and 200 µg/mL. After TAS treatment, the SGC-7901 cells were transfected with a vector designed to knock down SIRT3 expression. We assessed cell proliferation, viability, and apoptosis using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT assay), colony formation assay, and flow cytometry. SIRT3 expression was measured by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). Fe, malondialdehyde (MDA), lactate dehydrogenase (LDH), and superoxide dismutase assay kits were used to detect the level of reactive oxygen species (ROS) by fluorescent probe assay. Western blot was used to detect apoptosis-related proteins and SIRT3 protein expression. RESULTS: TAS dose-dependently inhibited SGC-7901 cell proliferation and viability (P<0.05) and induced apoptosis (P<0.05). TAS promoted the expression of SIRT3 and ACSL4 proteins (P<0.05), inhibited the expression of SLC7A11 and GPX4 proteins (P<0.05), and induced ferroptosis of SGC-7901 cells (P<0.05). Knockdown of the SIRT3 gene attenuated the effect of TAS treatment on ferroptosis (P<0.05). CONCLUSIONS: TAS has therapeutic potential for GC and can effectively inhibit the proliferation and viability of SGC-7901 cells, and the mechanism may be that TAS upregulates SIRT3 to promote the ferroptosis of SGC-7901 cells.
背景:胃癌(GC)是一种起源于胃黏膜上皮细胞的消化道恶性肿瘤,具有高度侵袭性和异质性,对人类健康构成严重威胁。近年来,铁死亡作为一种新型程序性细胞死亡方式,在肿瘤治疗中显示出潜在的抗癌作用。黄芪总皂苷(TAS)是从黄芪中提取的一种天然产物,已被证明具有多种药理活性,包括抗癌作用。本研究旨在探讨TAS对GC细胞的影响,重点研究其通过调节沉默信息调节因子3(SIRT3)诱导GC细胞铁死亡的作用机制。 方法:我们用浓度为50、100和200μg/mL的TAS处理SGC-7901细胞。TAS处理后,用设计用于敲低SIRT3表达的载体转染SGC-7901细胞。我们使用3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT法)、集落形成试验和流式细胞术评估细胞增殖、活力和凋亡。通过实时定量逆转录聚合酶链反应(qRT-PCR)检测SIRT3表达。使用铁、丙二醛(MDA)、乳酸脱氢酶(LDH)和超氧化物歧化酶检测试剂盒通过荧光探针法检测活性氧(ROS)水平。蛋白质免疫印迹法用于检测凋亡相关蛋白和SIRT3蛋白表达。 结果:TAS剂量依赖性地抑制SGC-7901细胞增殖和活力(P<0.05)并诱导凋亡(P<0.05)。TAS促进SIRT3和ACSL4蛋白表达(P<0.05),抑制SLC7A11和GPX4蛋白表达(P<0.05),并诱导SGC-7901细胞铁死亡(P<0.05)。敲低SIRT3基因减弱了TAS处理对铁死亡的影响(P<0.05)。 结论:TAS对GC具有治疗潜力,可有效抑制SGC-7901细胞的增殖和活力,其机制可能是TAS上调SIRT3以促进SGC-7901细胞铁死亡。
Transl Cancer Res. 2025-2-28
Zhongguo Zhong Yao Za Zhi. 2024-5
Zhongguo Zhong Yao Za Zhi. 2024-12
Trends Pharmacol Sci. 2024-8